Warby Parker Inc. Class A (WRBY)
NYSE: WRBYHealth CareOphthalmic GoodsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 25.31 0.00%
WRBY stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.13B
- P/E (TTM)
- 421.83
- Forward P/E
- 41.17
- EPS (TTM)
- $0.06
- Dividend yield
- None
- 52-week range
- 14.96 – 31.00
- Day range
- 25.29 – 26.41
- Volume / Avg
- 1.73M / 2.86M
- Beta
- —
- Shares outstanding
- 108.24M
- Next earnings
- Nov 5, 2026
52-week range
WRBY stock today
Warby Parker (WRBY) closed at $25.31 on Oct 7, down 3.51% (-$0.92), versus the S&P 500's 0.22% decline. At this level, WRBY sits in the middle of its 52-week range of $14.96 to $31.00: 18.4% below the high, set on Dec 11, 2025 and 69.2% above the low. WRBY is up 16.8% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 3.0%.
At 421.8x trailing earnings, Warby Parker trades above the peer-group median of 37.4x. Its forward P/E of 41.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Warby Parker's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Warby Parker
Company profileWarby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada. The company offers eyeglasses and sunglasses; and single-vision, progressive, light-responsive, polarized, blue-light-filtering, tinted, non-prescription, and contact lenses.
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- CEO
- Mr. Neil Harris Blumenthal
- Headquarters
- New York, NY
- Employees
- 2,275
- IPO year
- 2021
- Website
- warbyparker.com
Analyst forecast
ForecastConsensus (14 analysts)
buy
Avg. price target
$30.46+20.35%
- Strong buy 2
- Buy 8
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $0.03
Warby Parker peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| EYENational Vision Holdings Inc. | 16.82 | +0.48% | $1.33B | vs WRBY |
| STAASTAAR Surgical Company | 22.36 | +0.95% | $1.12B | vs WRBY |
| BLCOBausch + Lomb Corporation | 17.34 | +0.93% | $6.19B | vs WRBY |
| RXSTRxSight Inc. | 4.80 | +3.23% | $199.65M | vs WRBY |
| LUCYInnovative Eyewear Inc. | 0.912 | -0.88% | $7.95M | vs WRBY |
| COOThe Cooper Companies Inc. | 54.75 | -2.98% | $10.41B | vs WRBY |
| ALCAlcon Inc. | 63.00 | -0.30% | $30.45B | vs WRBY |
Indexes, lists and sector
Warby Parker stock FAQ
What is Warby Parker's stock price today?
WRBY last traded at $25.31 as of Oct 7, 4:00 PM EDT, down 3.51% on the day. Prices are delayed at least 15 minutes.
When is Warby Parker's next earnings date?
Warby Parker is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $0.03.
What is WRBY's P/E ratio?
WRBY trades at a trailing P/E ratio of 421.83 and a forward P/E of 41.17, compared with a median of 37.4 for its closest peers.
Who is Warby Parker's CEO?
Mr. Neil Harris Blumenthal is the chief executive officer of Warby Parker Inc. Class A, which has about 2,275 employees.
What is the WRBY 52-week high?
The 52-week high for WRBY is $31.00 and the 52-week low is $14.96. The stock is currently 18.4% below its high.